GRAND ACCELERATEUR NATIONAL D'IONS LOURDS

Their core work

GANIL is one of the world's leading ion beam accelerator facilities, located in Caen, France. It produces and accelerates beams of heavy ions and radioactive isotopes for fundamental nuclear physics research, astrophysics studies, and applied sciences including medical isotope production and radiation testing of electronics. The facility serves as a major European research infrastructure, hosting hundreds of international experiments annually and currently undergoing expansion through the SPIRAL2 project to deliver next-generation radioactive ion beams.

What they specialise in

How they've shifted over time

In the early H2020 period (2016–2018), GANIL focused on consolidating its position as a flagship nuclear physics infrastructure — coordinating large-scale projects like ENSAR2 and IDEAAL to develop and internationalize the facility. From 2019 onward, the focus shifted markedly toward applied outputs: medical isotope production (PRISMAP), laser spectroscopy of actinides (LISA), nuclear astrophysics infrastructure (ChETEC-INFRA), and radiation testing services for industry (RADNEXT). This evolution shows a facility moving from pure infrastructure building to translating its accelerator capabilities into health, space, and industrial applications.

GANIL is pivoting from fundamental nuclear physics infrastructure toward applied domains — medical isotopes, radiation-hardened electronics, and astrophysics — making it increasingly relevant to health-tech and space-industry partners.

How they like to work

GANIL operates as both a consortium leader and a specialist infrastructure contributor. It coordinated its two largest projects (ENSAR2, IDEAAL) but primarily joins as a participant in others, providing beam time and technical expertise. With 110 unique partners across 25 countries, it functions as a well-connected hub in the European nuclear and accelerator research community — typical of a large-scale user facility that attracts diverse international collaborators rather than relying on a fixed group.

GANIL has collaborated with 110 distinct partners across 25 countries, reflecting its role as a major European user facility that draws researchers from across the continent and beyond. Its network spans universities, national labs, and increasingly industry-adjacent partners in medical and electronics sectors.

What sets them apart

GANIL is one of only a handful of facilities in Europe capable of producing exotic radioactive ion beams and heavy ion beams at the energies needed for advanced nuclear physics, isotope production, and radiation testing. Its SPIRAL2 extension makes it a future-proof infrastructure investment. For consortium builders, GANIL brings not just scientific expertise but actual beam time and experimental infrastructure — a tangible asset that most partners cannot replicate.

Highlights from their portfolio

• ENSAR2
  Largest project by funding (EUR 1.57M to GANIL) and their flagship coordination effort — a pan-European nuclear science infrastructure network.
• PRISMAP
  Represents GANIL's strategic move into medical isotope production, connecting accelerator physics directly to cancer treatment and precision medicine.
• RADNEXT
  Opens GANIL's beam facilities to automotive, avionics, and space industries for radiation hardness testing — their clearest industry-facing project.